Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells

Journal of Immunology

Volumn 183, Issue 5, 2009, Pages 3481-3487

  Basu, Dhiman ^a   Liu, Ying ^a   Wu, Ailing ^a   Yarlagadda, Sushma ^a   Gorelik, Gabriela J ^a   Kaplan, Mariana J ^a   Hewagama, Anura ^a   Hinderer, Robert C ^a   Strickland, Faith M ^a   Richardson, Bruce C ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KIR2DL4 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIGEN; CROSS LINKING REAGENT; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KIR2DL4 PROTEIN, HUMAN; KIR3DL1 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CELL KILLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMETHYLATION; DISEASE ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CYTOTOXICITY TEST; DNA METHYLATION; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION; T LYMPHOCYTE SUBPOPULATION;

AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-LINKING REAGENTS; CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA METHYLATION; FEMALE; HUMANS; INTERFERON-GAMMA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MALE; RECEPTORS, KIR; RECEPTORS, KIR2DL4; RECEPTORS, KIR3DL1; T-LYMPHOCYTE SUBSETS;

EID: 70349260307     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900034     Document Type: Article

References (38)

1. + T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92: 38-53.
2. Yung, R. L., J. Quddus, C. E. Chrisp, K. J. Johnson, and B. C. Richardson. 1995. Mechanism of drug-induced lupus, I: Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154: 3025-3035.
3. Sawalha, A. H., M. Jeffries, R. Webb, Q. Lu, G. Gorelik, D. Ray, J. Osban, N. Knowlton, K. Johnson, and B. Richardson. 2008. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 9: 368-378.
4. Yung, R. L., and B. C. Richardson. 1994. Drug-induced lupus. Rheum. Dis. Clin. N. Am. 20: 61-86.
5. Lu, Q., M. Kaplan, D. Ray, D. Ray, S. Zacharek, D. Gutsch, and B. Richardson. 2002. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 46: 1282-1291.
6. Yung, R., D. Powers, K. Johnson, E. Amento, D. Carr, T. Laing, J. Yang, S. Chang, N. Hemati, and B. Richardson. 1996. Mechanisms of drug-induced lupus, II: T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J. Clin. Invest. 97: 2866-2871.
7. + lupus T cells. J. Immunol. 172: 3652-3661.
8. Lu, Q., A. Wu, D. Ray, C. Deng, J. Attwood, S. Hanash, M. Pipkin, M. Lichtenheld, and B. Richardson. 2003. DNA methylation and chromatin structure regulate T cell perforin gene expression. J. Immunol. 170: 5124-5132. (Pubitemid 36554744)
9. Lu, Q., A. Wu, L. Tesmer, D. Ray, N. Yousif, and B. Richardson. 2007. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179: 6352-6358.
10. Lu, Q., A. Wu, and B. C. Richardson. 2005. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 174: 6212-6219. (Pubitemid 40663812)
11. Liu, Y., R. Kuick, S. Hanash, and B. Richardson. 2008. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin. Immunol. 130: 213-224.
12. Vilches, C., and P. Parham. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20: 217-251.
13. Natarajan, K., N. Dimasi, J. Wang, R. A. Mariuzza, and D. H. Margulies. 2002. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 20: 853-885.
14. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
15. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang. 1992. Derivation of the SLEDAI: a disease activity index for lupus patients: The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35: 630-640.
16. Oelke, K., Q. Lu, D. Richardson, A. Wu, C. Deng, S. Hanash, and B. Richardson. 2004. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 50: 1850-1860. (Pubitemid 38725098)
17. Richardson, B. C., J. R. Strahler, T. S. Pivirotto, J. Quddus, G. E. Bayliss, L. A. Gross, K. S. O'Rourke, D. Powers, S. M. Hanash, and M. A. Johnson. 1992. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum. 35: 647-662.
18. Hsu, K. C., S. Chida, D. E. Geraghty, and B. Dupont. 2002. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol. Rev. 190: 40-52.
19. Denis, L., J. Sivula, P. A. Gourraud, N. Kerdudou, R. Chout, C. Ricard, J. P. Moisan, K. Gagne, J. Partanen, and J. D. Bignon. 2005. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 66: 267-276.
20. Nakajima, T., O. Goek, X. Zhang, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand. 2003. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ. Res. 93: 106-113.
21. Nakajima, T., S. Schulte, K. J. Warrington, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand. 2002. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105: 570-575.
22. - T cells in the aging immune system. Mech. Ageing Dev. 102: 131-147.
23. null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 165: 1138-1145.
24. Liu, Y., R. Kuick, M. Hanash, and B. Richardson. 2009. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin. Immunl. 130: 213-224.
25. Momot, T., R. E. Schmidt, and T. Witte. 2006. Regulation of killer immunoglobulin-like receptors in systemic lupus erythematosus. J. Rheumatol. 33: 1029.
26. + T cells. J. Exp. Med. 197: 437-449.
27. Richardson, B. 1986. Effect of an inhibitor of DNA methylation on T cells, II: 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum. Immunol. 17: 456-470. (Pubitemid 17198980)
28. Michel, J. J., C. Turesson, B. Lemster, S. R. Atkins, C. Iclozan, T. Bongartz, M. C. Wasko, E. L. Matteson, and A. N. Vallejo. 2007. CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthritis Rheum. 56: 43-57.
29. Crow, M. K. 2007. Type I interferon in systemic lupus erythematosus. Curr. Top. Microbiol. Immunol. 316: 359-386.
30. Seery, J. P. 2000. IFN-γ transgenic mice: clues to the pathogenesis of systemic lupus erythematosus? Arthritis Res. 2: 437-440. (Pubitemid 32223784)
31. Denny, M. F., P. Chandaroy, P. D. Killen, R. Caricchio, E. E. Lewis, B. C. Richardson, K. D. Lee, J. Gavalchin, and M. J. Kaplan. 2006. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J. Immunol. 176: 2095-2104.
32. Ohtsuka, K., J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz. 1998. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 160: 2539-2545. (Pubitemid 28119941)
33. Santourlidis, S., H. I. Trompeter, S. Weinhold, B. Eisermann, K. L. Meyer, P. Wernet, and M. Uhrberg. 2002. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169: 4253-4261.
34. Verthelyi, D., K. J. Ishii, M. Gursel, F. Takeshita, and D. M. Klinman. 2001. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166: 2372-2377.
35. Paget, C., E. Bialecki, J. Fontaine, C. Vendeville, T. Mallevaey, C. Faveeuw, and F. Trottein. 2009. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. J. Immunol. 182: 1846-1853.
36. Sato, Y., M. Miyata, T. Nishimaki, H. Kochi, and R. Kasukawa. 1999. CpG motif-containing DNA fragments from sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro. J. Rheumatol. 26: 294-301. (Pubitemid 29066731)
37. Zeuner, R. A., D. M. Klinman, G. Illei, C. Yarboro, K. J. Ishii, M. Gursel, and D. Verthelyi. 2003. Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides. Rheumatology (Oxford) 42: 563-569.
38. + double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44: 1127-1138.